Secretory carcinoma of the breast and its histopathological mimics: Value of markers for differential diagnosis

Histopathology

Volumn 63, Issue 4, 2013, Pages 509-519

  Osako, Tomo ^a,b   Takeuchi, Kengo ^a   Horii, Rie ^b   Iwase, Takuji ^b   Akiyama, Futoshi ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Acinic cell carcinoma; Adipophilin; Cystic hypersecretory carcinoma; ETV6 NTRK3 gene rearrangement; Secretory carcinoma

Indexed keywords

ADIPOPHILIN; ALPHA 1 ANTITRYPSIN; ALPHA LACTALBUMIN; AMYLASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LYSOZYME; MARKER; PROGESTERONE RECEPTOR; PROTEIN S 100;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST SECRETORY CARCINOMA; CANCER MORPHOLOGY; CARCINOMA; CLINICAL ARTICLE; CYSTIC HYPERSECRETORY CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL;

ACINIC CELL CARCINOMA; ADIPOPHILIN; CYSTIC HYPERSECRETORY CARCINOMA; ETV6-NTRK3 GENE REARRANGEMENT; SECRETORY CARCINOMA;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, ACINAR CELL; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84884713818     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12172     Document Type: Article

References (41)

1. McDivitt RW, Stewart FW. Breast carcinoma in children. JAMA 1966; 195; 388-390.
2. Norris NJ, Taylor HB. Carcinoma of the breast in women less than thirty years old. Cancer 1970; 26; 953-959.
3. Lakhani SR. Who classification of tumours of the breast, 4th edn. Lyon: International Agency for Research on Cancer, 2012.
4. Botta G, Fessia L, Ghiringhello B. Juvenile milk protein secreting carcinoma. Virchows Arch. A Pathol. Anat. Histol. 1982; 395; 145-152.
5. Lamovec J, Bracko M. Secretory carcinoma of the breast: light microscopical, immunohistochemical and flow cytometric study. Mod. Pathol. 1994; 7; 475-479.
6. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2; 367-376.
7. Li Z, Tognon CE, Godinho FJ et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of ap1 complex. Cancer Cell 2007; 12; 542-558.
8. Makretsov N, He M, Hayes M et al. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosom. Cancer 2004; 40; 152-157.
9. Hirokawa M, Sugihara K, Sai T et al. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma? Histopathology 2002; 40; 223-229.
10. Skalova A, Ryska A, Kajo K, Di Palma S, Kinkor Z, Michal M. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases. Histopathology 2005; 46; 43-49.
11. Diallo R, Tognon C, Knezevich SR, Sorensen P, Poremba C. Secretory carcinoma of the breast: a genetically defined carcinoma entity. Verh. Dtsch. Ges. Pathol. 2003; 87; 193-203.
12. Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology 1979; 3; 407-419.
13. Tavassoli FA, Eusebi V. AFIP atlas of tumor pathology. Tumors of the mammary gland. Washington, DC: American Registry of Pathology, 2009.
14. Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the breast. Virchows Arch. 1996; 429; 69-74.
15. Damiani S, Pasquinelli G, Lamovec J, Peterse JL, Eusebi V. Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study. Virchows Arch. 2000; 437; 74-81.
16. Peintinger F, Leibl S, Reitsamer R, Moinfar F. Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature. Histopathology 2004; 45; 645-648.
17. Reis-Filho JS, Natrajan R, Vatcheva R et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6 'split apart' probes. Histopathology 2008; 52; 840-846.
18. Rosen PP, Scott M. Cystic hypersecretory duct carcinoma of the breast. Am. J. Surg. Pathol. 1984; 8; 31-41.
19. Rosen PP. Rosen's breast pathology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2009.
20. Tavassoli FA, Norris HJ. Secretory carcinoma of the breast. Cancer 1980; 45; 2404-2413.
21. Guerry P, Erlandson RA, Rosen PP. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients. Cancer 1988; 61; 1611-1620.
22. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) pathology section. Jpn. J. Clin. Oncol. 1998; 28; 486-491.
23. Wolff AC, Hammond ME, Schwartz JN et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007; 25; 118-145.
24. Tanahashi C, Yabuki S, Akamine N, Yatabe Y, Ichihara S. Pure acinic cell carcinoma of the breast in an 80-year-old Japanese woman. Pathol. Int. 2007; 57; 43-46.
25. Chang ED, Lee EJ, Lee AW, Kim JS, Kang CS. Primary acinic cell carcinoma of the breast: a case report with an immunohistochemical and ultrastructural studies. J. Breast Cancer 2011; 14; 160-164.
26. Letessier A, Ginestier C, Charafe-Jauffret E et al. ETV6 gene rearrangements in invasive breast carcinoma. Genes Chromosom. Cancer 2005; 44; 103-108.
27. Eguchi M, Eguchi-Ishimae M, Tojo A et al. Fusion of ETV6 to neurotrophin-3 receptor trkc in acute myeloid leukemia with t(12;15) (p13;q25). Blood 1999; 93; 1355-1363.
28. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 1998; 18; 184-187.
29. Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998; 58; 5046-5048.
30. Fehr A, Loning T, Stenman G. Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion. Am. J. Surg. Pathol. 2011; 35; 1600-1602.
31. Skalova A, Vanecek T, Sima R et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 2010; 34; 599-608.
32. Foschini MP, Krausz T. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including 'triple negative carcinomas' of low malignant potential. Semin. Diagn. Pathol. 2010; 27; 77-90.
33. Matoso A, Easley SE, Gnepp DR, Mangray S. Salivary gland acinar-like differentiation of the breast. Histopathology 2009; 54; 262-263.
34. Kinkor Z, Skalova A. Acinic cell-like differentiation in invasive ductal carcinoma and in ductal hyperplasia of the breast - report of two cases. Ceskosl. Patol. 2005; 41; 29-33. [in Czech with English abstract].
35. Muthusamy K, Halbert G, Roberts F. Immunohistochemical staining for adipophilin, perilipin and tip47. J. Clin. Pathol. 2006; 59; 1166-1170.
36. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 1998; 294; 309-321.
37. Chong BM, Reigan P, Mayle-Combs KD, Orlicky DJ, McManaman JL. Determinants of adipophilin function in milk lipid formation and secretion. Trends Endocrinol. Metab. 2011; 22; 211-217.
38. Lae M, Freneaux P, Sastre-Garau X, Chouchane O, Sigal-Zafrani B, Vincent-Salomon A. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod. Pathol. 2009; 22; 291-298.
39. Dent R, Trudeau M, Pritchard KI et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 2007; 13; 4429-4434.
40. Clement PB, Azzopardi JG. Microglandular adenosis of the breast - a lesion simulating tubular carcinoma. Histopathology 1983; 7; 169-180.
41. Tavassoli FA, Norris HJ. Microglandular adenosis of the breast. A clinicopathologic study of 11 cases with ultrastructural observations. Am. J. Surg. Pathol. 1983; 7; 731-737.